The anti-inflammatory and anti-cancer properties of epigallocatechin-3- gallate are mediated by folate cycle disruption, adenosine release and NF-κB suppression

Inflammation Research

Volumn 57, Issue 10, 2008, Pages 472-478

  Navarro Peran E ^a   Cabezas Herrera, J ^b   Sanchez Del Campo L ^a   Garcia Canovas F ^a   Rodriguez Lopez J N ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Adenosine; Epigallocatechin 3 gallate; Folic acid; Green tea; NF B pathway

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; EPIGALLOCATECHIN GALLATE; FOLIC ACID; FOLIC ACID ANTAGONIST; FOLINIC ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE; PROTEIN KINASE B;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING;

ADENOSINE; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CACO-2 CELLS; CATECHIN; COLONIC NEOPLASMS; FOLIC ACID; HUMANS; I-KAPPA B PROTEINS; LEUCOVORIN; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN B COMPLEX;

EID: 58149242344     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-8013-x     Document Type: Article

References (36)

1. Navarro-Perán E, Cabezas-Herrera J, García-Cánovas F, Durrant MC, Thorneley RNF, Rodríguez-López JN. The antifolate activity of tea catechins. Cancer Res 2005;65:2059-64.
2. Navarro-Perán E, Cabezas-Herrera J, Hiner ANP, Sadunishvili T, García-Cánovas F, Rodríguez-López JN. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies. Biochemistry 2005;44:7512-25.
3. Alemdaroglu NC, Wolffram S, Boissel JP, Closs E, Spahn-Langguth H, Langguth, P. Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells. Planta Med 2007; 73:27-32.
4. Sueoka N, Suganuma M, Sueoka E, et al. A new function of green tea: prevention of lifestyle-related diseases. Ann NY Acad Sci 2001;928:274-80.
5. Alic M. Green tea for remission maintenance in Crohn's disease? Am J Gastroenterol 1999;94:1710-1.
6. Yang F, Chung JY, Yang GY, Li C, Meng X, Lee MJ. Mechanisms of inhibition of carcinogenesis by tea. Biofactors 2000;13:73-9.
7. Berman EM, Werbel LM. The renewed potential for folate antagonists in contemporary cancer chemotherapy. J Med Chem 1991;34:479-85.
8. Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis 2001;60:729-35.
9. Balkwill F, Coussens LM. An inflammatory link. Nature 2004;431:405-6.
10. Aggarwal BB. Nuclear factor-κB: the enemy within. Cancer Cell 2004;6:203-8.
11. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6.
12. Majumdar S, Aggarwal BB. Methotrexate suppresses NF-κB activation through inhibition of IκBα phosphorylation and degradation. J Immunol 2001;167:2911-20.
13. Linden J. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001;41:775-87.
14. Ochaion A, Bar-Yehuda S, Cohn S, et al. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression. Arthritis Res Ther 2006;8:R169.
15. Singh R, Fouladi-Nashta AA, Li D, Halliday N, Barret DA, Sinclair KD. Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation. J Cell Biochem 2006;99:146-55.
16. Mu LN, Lu QY, Yu SZ, et al. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 2005;116:972-83.
17. Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3- gallate differentially modulates nuclear factor κB in cancer cells versus normal cells. Arch Biochem Biophys 2000;376:338-46.
18. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995;9:2723-35.
19. Kim S, Jee K, Kim D, Koh H, Chung J. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J Biol Chem 2001;276:12864-70.
20. Yu L, Yu H, Yu J, Luo H, Xu X, Li J. Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J Gastroenterol 2004;10:3255-60.
21. 1-activated NF-κB DNA binding in the basal forebrain of the rat. Neuroscience 2001;104:731-9.
22. Seitz M. Molecular and cellular effects of methotrexate. Curr Opin Rheumatol 1999;11:226-32.
23. Song G, Ouyang G, Bao S. The activation of AKT/PKB signalling pathway and cell survival. J Cell Mol Med 2005;9:59-71.
24. Mello SB, Barros DM, Silva AS, Laurindo IM, Novaes GS. Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis. Rheumatology 2000;39:533-6.
25. Hussain T, Gupta S, Adhami VM, Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 2005;113:660-9.
26. Robbins RA, Jinkins PA, Bryan TW, Prado SC, Milligan SA. Methotrexate inhibition of inducible nitric oxide synthase in murine lung epithelial cells in vitro. Am J Respir Cell Mol Biol 1998;18:853-9.
27. Lin YL, Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-?B. Mol Pharmacol 1997;52:465-72.
28. Kim CH, Moon SK. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells. Arch Biochem Biophys 2005;435:264-72.
29. Gingras D, Béliveau R. Green tea: prevention and treatment of cancer by nutraceuticals. Lancet 2004;364:1021-2.
30. Johnston A, Gudjonsson JE, Sigmundsdottir H, Ludviksson BR, Valdimarsson H. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin Immunol 2005;114:154-63.
31. Fishman P, Bar-Yehuda S, Ohana G, et al. An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3β and NF-κB. Oncogene 2004;23:2465-71.
32. Delghandi MP, Johannessen M, Moens U. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cel. Signal 2005;17:1343-51.
33. Huh SW, Bae SM, Kim YW, et al. Anticancer effects of (-)- epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol 2004;94:760-8.
34. Ju J, Hong J, Zhou JN, et al. Inhibition of intestinal tumorigenesis in Apc(min/+) mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 2005;65:10623-31.
35. Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3- gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 2004;279:12755-62.
36. González-Yanes C, Sánchez-Margalet V. Signalling mechanisms regulating lipolysis. Cell Signal 2006;18:401-8.